stockrowU.S. Physical Therapy, Inc.
USPH Healthcare Medical Care Facilities
U.S. Physical Therapy, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $781.0 million, up 16.3% from fiscal 2024.
- Revenue
- +12.9%
- EPS
- −316.7%
- Free cash flow
- +32.2%
- Total debt
- +59.6%
Quarter to September 2026, against a year earlier
Follow USPH
Alert me
U.S. Physical Therapy, Inc. (USPH) EV/Sales
As of 5 November 2026, U.S. Physical Therapy, Inc. (USPH) trades at a EV/Sales of 2.0×. Over the past ten years it has ranged from 1.3× (March 2020) to 4.3× (February 2021); the current reading is higher than 22% of that period. That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.7× | (22.14%) |
| FY2024 | 2.1× | (1.32%) |
| FY2023 | 2.2× | (0.38%) |
| FY2022 | 2.2× | (18.41%) |
| FY2021 | 2.7× | (26.06%) |
| FY2020 | 3.6× | 17.14% |
| FY2019 | 3.1× | 6.68% |
| FY2018 | 2.9× | 24.86% |
| FY2017 | 2.3× | (9.95%) |
| FY2016 | 2.6× | 22.01% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.8× | 17.35% |
| Jun 2026 | 1.5× | (7.84%) |
| Mar 2026 | 1.6× | (1.79%) |
| Dec 2025 | 1.7× | (10.41%) |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CMPS COMPASS Pathways PLC Sponsored ADR compare | n/m |
| AGL Agilon Health, Inc. compare | 0.3× |
| ARDT Ardent Health, Inc. compare | 0.4× |
| HCSG Healthcare Services Group, Inc. compare | 0.8× |
| INNV InnovAge Holding Corp. compare | 1.1× |
| PNTG The Pennant Group, Inc. compare | 1.3× |
| NUTX Nutex Health Inc. compare | 1.7× |
| USPH U.S. Physical Therapy, Inc. | 2.0× |
| SNDA Sonida Senior Living, Inc. compare | 4.8× |
| Medical Care Facilities industry median | 1.4× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)